Aptose Biosciences (TSE:APS) Share Price Passes Below 200-Day Moving Average – Here’s Why

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$0.96 and traded as low as C$0.52. Aptose Biosciences shares last traded at C$0.53, with a volume of 4,100 shares.

Aptose Biosciences Stock Performance

The stock has a fifty day simple moving average of C$0.52 and a 200-day simple moving average of C$0.96. The stock has a market cap of C$9.60 million, a P/E ratio of -0.09 and a beta of 1.36. The company has a debt-to-equity ratio of 670.80, a quick ratio of 5.41 and a current ratio of 0.80.

Aptose Biosciences (TSE:APS) (NASDAQ:APTO) last announced its earnings results on Thursday, August 8th. The biotechnology company reported C($0.59) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C($0.80) by C$0.21. On average, equities analysts expect that Aptose Biosciences Inc. will post -0.59 earnings per share for the current year.

Aptose Biosciences Company Profile

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.